Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
SPONSORS MEMBERS (as of December 31, 2018) (as of December 31, 2018)â Financial support for the Forum is derived from government Forum membership includes a diverse agencies, industry sponsors, private foundations, and range of stakeholders from multiple sectors, nonprofit associations. including government, biopharmaceutical industry, biomedical research funders and Government Private Foundation sponsors, academia, foundations, consortia, Center for Drug Evaluation and Burroughs Wellcome Fund disease advocacy, and patient-focused Research (FDA) groups. National Cancer Institute (NIH) Nonprofit Organizations National Center for Advancing American Diabetes Association Translational Sciences (NIH) Association of American Medical Russ Altman (Co-Chair) National Institute of Allergy and Colleges Stanford University Infectious Diseases (NIH) Critical Path Institute Robert Califf (Co-Chair) National Institute of Mental Health (NIH) FasterCures Duke University and Verily Life Sciences National Institute of Neurological Foundation for the National Institutes Christopher Austin Disorders and Stroke (NIH) of Health National Center for Advancing Translational Office of Science Policy (NIH) Friends of Cancer Research Sciences, NIH New England Journal of Medicine Linda Brady Industry National Institute of Mental Health, NIH AbbVie Inc. Amgen Inc. Tanisha Carino AstraZeneca FasterCures Eli Lilly and Company Tamara Darsow GlaxoSmithKline American Diabetes Association Johnson & Johnson (until May 2018) Merck & Co., Inc. Richard Davey Pfizer Inc. National Institute of Allergy and Infectious Sanofi Diseases, NIH Takeda Pharmaceuticals (as of June 2018) Lori Dodd National Institute of Allergy and Infectious Diseases, NIH (until June 2018) 22
Forum Sponsorship and Membership James Doroshow Joseph Menetski National Cancer Institute, NIH Foundation for the National Jeffrey Drazen Institutes of Health New England Journal of Medicine Bernard Munos Membership Steven Galson InnoThink Center for Research in Amgen Inc. Biomedical Innovation Carlos Garner Michael Severino Eli Lilly and Company AbbVie Inc. Rachel Sherman Other* Biopharma Julie Gerberding 31% 31% Merck & Co., Inc. Office of the Commissioner, FDA Lynn Hudson Ellen Sigal Critical Path Institute Friends of Cancer Research Academia Jeff Hurd Lana Skirboll 13% Federal Sanofi 25% AstraZeneca (as of September 2018) Brian Strom S. Claiborne Johnston Rutgers, The State University of New Jersey *Consortia, Foundations, Dell Medical School, The University Journals, Patient-Focused/ of Texas at Austin Amir Tamiz Disease Advocacy Organizations Gregory Keenan National Institute of Neurological AstraZeneca Disorders and Stroke, NIH (until September 2018) Pamela Tenaerts Rusty Kelley Clinical Trials Transformation Burroughs Wellcome Fund Initiative Katharine Knobil John Wagner GlaxoSmithKline Takeda Pharmaceuticals Freda Lewis-Hall Joanne Waldstreicher Pfizer Inc. Johnson & Johnson Allison McElvaine Carrie Wolinetz American Diabetes Association Office of Science Policy, NIH (as of May 2018) Janet Woodcock Ross McKinney Center for Drug Evaluation and Association of American Medical Research, FDA Colleges 23
